Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from China Resources Pharmaceutical Group Ltd. ( (HK:3320) ) is now available.
China Resources Pharmaceutical Group Ltd. announced an interim dividend of RMB 0.072 per share for the six months ending June 30, 2025, with the option for shareholders to receive the dividend in Hong Kong dollars at an exchange rate of RMB 1 to HKD 1.0957. This announcement reflects the company’s stable financial performance and commitment to delivering shareholder value, potentially enhancing its market position and investor confidence.
The most recent analyst rating on (HK:3320) stock is a Buy with a HK$7.50 price target. To see the full list of analyst forecasts on China Resources Pharmaceutical Group Ltd. stock, see the HK:3320 Stock Forecast page.
More about China Resources Pharmaceutical Group Ltd.
China Resources Pharmaceutical Group Ltd. operates in the pharmaceutical industry, focusing on the production and distribution of pharmaceutical products and services. The company is a significant player in the market, providing a wide range of healthcare solutions.
Average Trading Volume: 12,295,656
Technical Sentiment Signal: Sell
Current Market Cap: HK$32.23B
See more data about 3320 stock on TipRanks’ Stock Analysis page.